睡眠呼吸障碍与卒中后结局:墨西哥裔美国人的差异贡献
基于社区缺血性卒中患者(n=995)的睡眠呼吸障碍研究,卒中后不久行家庭睡眠呼吸监测,90天评估神经、功能、认知及生活质量结局。睡眠呼吸障碍与更差的功能和认知结局相关,并解释9%至10%的种族结局差异。
要点
- 睡眠呼吸障碍与卒中后90天功能结局和认知结局变差独立相关。
- 睡眠呼吸障碍解释功能和认知结局种族差异的9%至10%。
- 睡眠呼吸障碍与认知结局的关联在墨西哥裔美国人中可能更强。
核心结论
- 睡眠呼吸障碍与卒中后90天更差的功能和认知功能相关。
- 睡眠呼吸障碍治疗可能在一定程度上减轻卒中结局的种族差异。
研究设计与样本
- 基于人群的脑卒中监测项目(2010-2015)纳入缺血性卒中患者n=995。
- 卒中后不久行家庭睡眠呼吸监测(ApneaLink Plus),以呼吸事件指数≥10定义睡眠呼吸障碍。
- 卒中后90天评估神经、功能、认知和生活质量结局,采用回归模型校正社会人口学、卒中前功能与认知、健康危险行为、卒中严重程度和血管危险因素。
主要发现
- 中位年龄67岁(IQR=59-78),62.1%为墨西哥裔美国人。
- 中位呼吸事件指数14(IQR=6-25),62.8%存在睡眠呼吸障碍。
- 睡眠呼吸障碍与更差的功能结局相关(日常生活活动/工具性日常生活活动评分平均差=0.15,95%CI=0.01-0.28)。
- 睡眠呼吸障碍与更差的认知结局相关(改良简易精神状态检查平均差=-2.66,95%CI=-4.85至-0.47)。
- 睡眠呼吸障碍与神经结局或生活质量结局无显著关联。
关键数值与推荐
- 睡眠呼吸障碍定义为呼吸事件指数≥10。
- 睡眠呼吸障碍解释功能和认知结局种族差异的9%至10%。
- 睡眠呼吸障碍与认知结局的关联:墨西哥裔美国人β=-3.97(95%CI=-6.63至-1.31),非西班牙裔白人β=-0.40(95%CI=-4.18至3.39),交互作用p=0.15。
临床怎么用
- 卒中后应关注睡眠呼吸障碍的筛查与评估,尤其对功能和认知结局高风险患者。
- 睡眠呼吸障碍可作为未来卒中治疗试验的合理终点。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the association between sleep-disordered breathing and stroke outcomes, and determine the contribution of sleep-disordered breathing to outcome disparities in Mexican Americans. METHODS: Ischemic stroke patients (n = 995), identified from the population-based Brain Attack Surveillance in Corpus Christi Project (2010-2015), were offered participation in a sleep-disordered breathing study including a home sleep apnea test (ApneaLink Plus). Sleep-disordered breathing (respiratory event index ≥10) was determined soon after stroke. Neurologic, functional, cognitive, and quality of life outcomes were assessed at 90 days poststroke. Regression models were used to assess associations between sleep-disordered breathing and outcomes, adjusted for sociodemographics, prestroke function and cognition, health-risk behaviors, stroke severity, and vascular risk factors. RESULTS: Median age was 67 years (interquartile range [IQR] = 59-78); 62.1% were Mexican American. Median respiratory event index was 14 (IQR = 6-25); 62.8% had sleep-disordered breathing. Sleep-disordered breathing was associated with worse functional outcome (mean difference in activities of daily living/instrumental activities of daily living score = 0.15, 95% confidence interval [CI] = 0.01-0.28) and cognitive outcome (mean difference in modified Mini-Mental State Examination = -2.66, 95% CI = -4.85 to -0.47) but not neurologic or quality of life outcomes. Sleep-disordered breathing accounted for 9 to 10% of ethnic differences in functional and cognitive outcome and was associated with cognitive outcome more strongly for Mexican Americans (β = -3.97, 95% CI = -6.63 to -1.31) than non-Hispanic whites (β = -0.40, 95% CI = -4.18 to 3.39, p-interaction = 0.15). INTERPRETATION: Sleep-disordered breathing is associated with worse functional and cognitive function at 90 days poststroke. These outcomes are reasonable endpoints for future trials of sleep-disordered breathing treatment in stroke. If effective, sleep-disordered breathing treatment may somewhat lessen ethnic stroke outcome disparities. ANN NEUROL 2019;86:241-250.
引用
- Lisabeth LD, Sánchez BN, Lim D, et al. Sleep-disordered breathing and poststroke outcomes. Ann Neurol. 2019. PMID: 31155749. doi:10.1002/ana.25515
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。